Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

353 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rethinking the Standard for Ductal Carcinoma In Situ Treatment.
Esserman L, Yau C. Esserman L, et al. JAMA Oncol. 2015 Oct;1(7):881-3. doi: 10.1001/jamaoncol.2015.2607. JAMA Oncol. 2015. PMID: 26291410 No abstract available.
Should we recommend screening mammography for women aged 40 to 49?
Esserman L, Kerlikowske K. Esserman L, et al. Oncology (Williston Park). 1996 Mar;10(3):357-64; discussion: 370-6. Oncology (Williston Park). 1996. PMID: 8820449 Review.
Management of ductal carcinoma in situ.
Hwang ES, Esserman LJ. Hwang ES, et al. Surg Clin North Am. 1999 Oct;79(5):1007-30, viii. doi: 10.1016/s0039-6109(05)70058-x. Surg Clin North Am. 1999. PMID: 10572548 Review.
Integration of breast imaging into cancer management.
Esserman LJ, Wolverton D, Hylton N. Esserman LJ, et al. Curr Oncol Rep. 2000 Nov;2(6):572-81. doi: 10.1007/s11912-000-0112-y. Curr Oncol Rep. 2000. PMID: 11122895 Review.
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.
Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. Esserman L, et al. Ann Surg Oncol. 2001 Jul;8(6):549-59. doi: 10.1007/s10434-001-0549-8. Ann Surg Oncol. 2001. PMID: 11456056
353 results
Jump to page
Feedback